🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of acetaminophen, alleging the firms concealed safety concerns that the drug posed to children's neurological development.

The lawsuit comes thirty days after President Donald Trump promoted an unproven link between consuming acetaminophen - referred to as paracetamol - while pregnant and autism in young ones.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the drug, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he stated they "betrayed America by gaining financially from suffering and pushing pills ignoring the dangers."

The manufacturer states there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, deliberately risking countless individuals to boost earnings," the attorney general, from the Republican party, said.

The manufacturer commented that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the likely effects that could have on the well-being of US mothers and children."

On its online platform, Kenvue also stated it had "regularly reviewed the applicable studies and there is insufficient valid information that demonstrates a verified association between consuming paracetamol and autism."

Associations representing medical professionals and health professionals agree.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to address pain and fever, which can present serious health risks if left untreated.

"In multiple decades of research on the use of paracetamol in pregnancy, zero credible investigations has conclusively proven that the use of paracetamol in any stage of pregnancy results in brain development issues in children," the organization said.

The court filing cites latest statements from the former administration in arguing the drug is potentially dangerous.

Last month, Trump raised alarms from medical authorities when he advised expectant mothers to "struggle intensely" not to take Tylenol when sick.

The US Food and Drug Administration then released a statement that doctors should contemplate reducing the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism spectrum disorder in young ones has not been proven.

The Health Department head RFK Jr, who oversees the Food and Drug Administration, had promised in April to conduct "extensive scientific investigation" that would identify the source of autism spectrum disorder in a limited time.

But specialists cautioned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a complicated interplay of genetic and surrounding conditions - would not be simple.

Autism is a category of permanent neurological difference and impairment that impacts how individuals experience and interact with the world, and is identified using doctors' observations.

In his legal document, Paxton - a Trump ally who is running for US Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the research" around acetaminophen and autism spectrum disorder.

The case seeks to make the companies "eliminate any marketing or advertising" that asserts acetaminophen is reliable for expectant mothers.

The Texas lawsuit echoes the concerns of a group of parents of young ones with autism and attention deficit hyperactivity disorder who took legal action against the makers of Tylenol in 2022.

Judicial authorities dismissed the legal action, stating research from the family's specialists was not conclusive.